X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The MicroDoz Therapy team is sponsoring a study to evaluate the effectiveness of psilocybin assisted in treating Cannabis Use Disorder in 12 patients.
Lead Product(s): Psilocybine
Therapeutic Area: Psychiatry/Psychology Product Name: Undisclosed
Highest Development Status: Phase IProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 13, 2022
Details:
Naltrexone is an opioid antagonist, primarily used to manage alcohol and or opioid use disorder by reducing cravings and feelings of euphoria associated with substance abuse disorder.
Lead Product(s): Naltrexone
Therapeutic Area: Psychiatry/Psychology Product Name: Undisclosed
Highest Development Status: UndisclosedProduct Type: Small molecule
Recipient: Naltrexone Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition October 11, 2022
Details:
The investment provides the shareholders with exposure to a rapidly developing therapeutics business, which just reported positive data from a phase 1 clinical trial evaluating the pharmacokinetics and safety of the company’s continuous delivery lenalidomide program.
Lead Product(s): Psychedelic-based Therapeutic
Therapeutic Area: Psychiatry/Psychology Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Small molecule
Recipient: Starton Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership September 08, 2022
Details:
This partnership and development program will add to the Company’s comprehensive portfolio of intellectual property and effort to be a frontrunner in the psychedelics and therapeutics including Psilocybin Infused Oral Strip as a product with the highest standard of efficacy.
Lead Product(s): Psilocybine
Therapeutic Area: Psychiatry/Psychology Product Name: Undisclosed
Highest Development Status: UndisclosedProduct Type: Small molecule
Recipient: MicroDoz Therapy Inc.
Deal Size: $0.8 million Upfront Cash: Undisclosed
Deal Type: Partnership November 23, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
